• Leslie R. Schover
Part of the MD Anderson Cancer Care Series book series (MDCCS)


Sexual dysfunction in men and women after treatment for cancer is one of the most common problems of survivorship, yet most survivors experiencing sexual dysfunction do not receive medical help. Left untreated, sexual dysfunction does not resolve, but instead persists over many years. Not all survivors are distressed about sexual dysfunction. Factors associated with distress include young age, being in a relationship, and having enjoyed sexuality before the cancer diagnosis. The most common problem for which men seek help is erectile dysfunction, although loss of desire for sex, difficulty reaching orgasm, and pain during sexual activity also occur after a number of treatments. Pelvic surgery and radiation are common causes of erectile dysfunction, but hypogonadism also sometimes occurs in survivors of intensive chemotherapy. In women, chemotherapy-induced ovarian failure is a major risk factor for vaginal dryness, dyspareunia, and consequent loss of interest in sex. Pelvic radiation therapy, surgery that changes vaginal or vulvar anatomy, or vaginal complications of graft-versus-host disease are also problematic. Oncology clinics should provide basic education, counseling, and referrals. The optimal treatment for sexual dysfunction is multidisciplinary, with a medical specialist and a mental health professional working together to assess the problem and create a treatment plan.


Erectile Dysfunction Sexual Function Sexual Dysfunction Sexual Arousal Radical Cystectomy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Suggested Readings

  1. Barnas JL, Pierpaoli S, Ladd P, et al. The prevalence and nature of orgasmic dysfunction after radical prostatectomy. BJU Int 2004;94:603–605.PubMedCrossRefGoogle Scholar
  2. Baumgart J, Nilsson K, Stavreus-Evers A, et al. Urogenital disorders in women with adjuvant endocrine therapy after early breast cancer. Am J Obstet Gynecol 2011;204:e1–e7.PubMedCrossRefGoogle Scholar
  3. Bhatt A, Nandipati K, Dhar N, et al. Neurovascular preservation in orthotopic cystectomy: impact on female sexual function. Urology 2006;67:742–745.PubMedCrossRefGoogle Scholar
  4. Carter J, Goldfrank D, Schover LR. Simple strategies for vaginal health promotion in cancer survivors. J Sex Med 2011;8:549–559.PubMedCrossRefGoogle Scholar
  5. Choi JM, Nelson CJ, Stasi J, Mulhall JP. Orgasm associated incontinence (climacturia) following radical pelvic surgery: rates of occurrence and predictors. J Urol 2007;177:2223–2226.PubMedCrossRefGoogle Scholar
  6. Frumovitz M, Sun CC, Schover LR, et al. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol 2005;23:7428–7436.PubMedCrossRefGoogle Scholar
  7. Gontero P, Galzerano M, Bartoletti R, et al. New insights into the pathogenesis of penile shortening after radical prostatectomy and the role of postoperative sexual function. J Urol 2007;178:602–607.PubMedCrossRefGoogle Scholar
  8. Huyghe E, Delannes M, Wagner F, et al. Ejaculatory function after permanent 125I prostate brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2009a;74:126–132.PubMedCrossRefGoogle Scholar
  9. Huyghe E, Sui D, Odensky E, Schover LR. Needs assessment survey to justify establishing a reproductive health clinic at a comprehensive cancer center. J Sex Med 2009b;6:149–163.PubMedCrossRefGoogle Scholar
  10. Laumann EO, Glasser DB, Neves RC, Moreira ED Jr; GSSAB Investigators’ Group. A population-based survey of sexual activity, sexual problems and associated help-seeking behavior patterns in mature adults in the United States of America. Int J Impot Res 2009;21:171–178.PubMedCrossRefGoogle Scholar
  11. Müller A, Parker M, Waters BW, Flanigan RC, Mulhall JP. Penile rehabilitation following radical prostatectomy: predicting success. J Sex Med 2009;6:2806–2812.PubMedCrossRefGoogle Scholar
  12. Pfaus JG. Pathways of sexual desire. J Sex Med 2009;6:1506–1533.PubMedCrossRefGoogle Scholar
  13. Rechis R, Boerner L. How cancer has affected post-treatment survivors: a Livestrong report, June 2010. Accessed November 5, 2013.
  14. Rowland JH, Mariotto A, Alfano CM, Pollack LA, Weir HK, White A. Cancer Survivors—United States, 2007. MMWR 2011;60:269–272.Google Scholar
  15. Sadovsky R, Basson R, Krychman M, et al. Cancer and sexual problems J Sex Med 2010;7:349–373.PubMedCrossRefGoogle Scholar
  16. Sandler HM, Mirhadi AJ. Current status of radiation therapy for bladder cancer. Expert Rev Anticancer Ther 2010;10:895–901.PubMedCrossRefGoogle Scholar
  17. Schover LR. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. J Clin Oncol 2008a;26:753–758.PubMedCrossRefGoogle Scholar
  18. Schover LR. Reduction of psychosexual dysfunction in cancer patients. In: Miller SM, Bowen DJ, Croyle RT, Rowland, JH, eds. Handbook of Cancer Control and Behavioral Science. Washington, DC: American Psychological Association Press; 2008b:379–390.Google Scholar
  19. Schover LR, Canada AL, Yuan Y, et al. A randomized trial of internet-based versus traditional sexual counseling for couples after localized prostate cancer treatment. Cancer 2012;118:500–509.PubMedCrossRefPubMedCentralGoogle Scholar
  20. Schover LR, Fouladi RT, Warnecke CL, et al. Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer 2002;95:1773–1785.PubMedCrossRefGoogle Scholar
  21. Schover LR, Ying Y, Fellman BM, Odensky E, Lewis PE, Martinetti P. Efficacy trial of an internet-based intervention for cancer-related female sexual dysfunction. J Natl Comp Cancer Network 2013;in press.Google Scholar
  22. Stratton P, Turner ML, Childs R, et al. Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation. Obstet Gynecol 2007;110:1041–1049.PubMedCrossRefGoogle Scholar
  23. Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2006;4:CD001500.Google Scholar
  24. Tal R, Alphs HH, Krebs P, Nelson CJ, Mulhall JP. Erectile function recovery rate after radical prostatectomy: a meta-analysis. J Sex Med 2009;6:2538–2546.PubMedCrossRefPubMedCentralGoogle Scholar
  25. Tal R, Heck M, Teloken P, Siegrist T, Nelson CJ, Mulhall JP. Peyronie’s disease following radical prostatectomy: incidence and predictors. J Sex Med 2010;7:1254–1261.PubMedCrossRefGoogle Scholar
  26. van der Wielen GJ, Mulhall JP, Incrocci L. Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review. Radiother Oncol 2007;84:107–113.PubMedCrossRefGoogle Scholar
  27. Winter C, Raman JD, Sheinfeld J, Albers P. Retroperitoneal lymph node dissection after chemotherapy. BJU Int 2009;104:1404–1412.PubMedCrossRefGoogle Scholar
  28. Yi JC, Syrjala KL. Sexuality after hematopoietic stem cell transplantation. Cancer J 2009;15:57–64.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© The University of Texas M. D. Anderson Cancer Center 2015

Authors and Affiliations

  • Leslie R. Schover
    • 1
  1. 1.Department of Behavioral ScienceThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations